SOURCE: Cryobanks International, Inc.

May 14, 2007 06:00 ET

Cryobanks International Celebrates Women's Health

Mother's Day and National Women's Health Week

ALTAMONTE SPRINGS, FL -- (MARKET WIRE) -- May 14, 2007 -- This Mother's Day and National Women's Health Week, Cryobanks International wants to remind everyone of the benefits of donating umbilical cord blood at birth and its uses in treating diseases that affect women.

For expectant mothers, giving birth to a new baby is the ultimate gift. It is also an opportunity to give the gift of life. Donating cord blood at birth could save the life of a family member or someone else in need. And, the collection is non-invasive, quick and painless to the baby and mother.

In fact, scientists predict that in the future the collection of cord blood at birth may become a routine part of the delivery process. Studies and new technology are making the collection, processing and storage of cord blood safer and more secure than ever.

Although cord blood was once considered medical waste, scientists now know it is a rich source of stem cells that help the body create cells that carry oxygen, fight disease and help stop bleeding. Doctors are using cord blood to treat a wide variety of cancers, blood disorders and metabolic diseases.

The future for umbilical cord blood research is endless. Research indicates that stem cells someday may be used to treat numerous other diseases that are growing in prevalence including Alzheimer's, diabetes, and heart disease.

Cryobanks is the only facility that accepts donated cord blood from anywhere in the Continental United States every day of the year. Cord blood donated to Cryobanks is listed on international registries; including the National Marrow Donor Program, where anyone in need of a potential life saving transplant can access it.

About Cryobanks:

Cryobanks International is a corporation located in Altamonte Springs, Florida. The Company is a leader in the collection, processing, and banking of stem cells derived from the umbilical cord immediately after birth. The units of cord blood (CB) are processed and stored by the company for use in unrelated transplants (where the donor is a histocompatible match, but is anonymous and unrelated to the recipient) and for personal storage and use. In recent years, cord blood transplants (CBTs) have become widely recognized as a safe, effective, and in many ways preferable, alternative to bone marrow transplant (BMT). There is tremendous potential need for CBTs in the United States and worldwide. Cryobanks International is well poised to help meet that need, equipped with an inventory of over 9,000 donated cord blood units listed on international registries including the National Marrow Donor Program. For more information about Cryobanks International call 1-800-869-8608 or visit the website at www.cryo-intl.com.

Safe Harbor Statement

This press release contains "forward-looking statements" by the Company. These statements relate to future events or financial performance and transactions, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements, to be materially different from those contemplated by the forward-looking statements. We undertake no ongoing obligation, other than that imposed by law, to update these statements.

Contact Information